Article Versions Notes

Gozzo L, Nardo A, Brancati S, Judica A, Duminuco A, Maugeri C, Parisi M, Longo L, Vitale DC, Ruscica R, et al. Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data. Healthcare. 2023; 11(10):1479. https://doi.org/10.3390/healthcare11101479

Gozzo, Lucia, Antonella Nardo, Serena Brancati, Antongiulio Judica, Andrea Duminuco, Cinzia Maugeri, Marina Parisi, Laura Longo, Daniela Cristina Vitale, Rosy Ruscica, and et al. 2023. "Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data" Healthcare 11, no. 10: 1479. https://doi.org/10.3390/healthcare11101479

Gozzo, L., Nardo, A., Brancati, S., Judica, A., Duminuco, A., Maugeri, C., Parisi, M., Longo, L., Vitale, D. C., Ruscica, R., Romano, G. L., Mauro, E., Fiumara, P. F., Palumbo, G. A. M., Di Raimondo, F., Vetro, C., & Drago, F. (2023). Severe Gastrointestinal Toxicity Following the Use of Gilteritinib: A Case Series and Analysis of Postmarketing Surveillance Data. Healthcare, 11(10), 1479. https://doi.org/10.3390/healthcare11101479